Antithrombin Market size is expected to reach nearly US$ 822.20 Mn. by 2029 with the CAGR of 4.5% during the forecast period.Antithrombin Market Overview:
Antithrombin (AT) is a small protein molecule that aids in the inactivation of coagulation system enzymes. It's often used during surgical procedures in patients with low antithrombic levels, and it serves as a natural blood thinner. Antithrombin is a serine protease inhibitor with a structure similar to alpha 1-antichymotrypsin, alpha 2-antiplasmin, and heparin cofactor II.To know about the Research Methodology :- Request Free Sample Report
Antithrombin Market Dynamics:
Rising prevalence of surgical procedures and advances in the technology are the major drivers for the market growth. Antithrombin is being used to treat many medical conditions such as sepsis, hereditary antithrombin deficiency, disseminated intravascular coagulation (DIC), and extracorporeal membrane oxygenation (ECMO). Increasing incidences of these conditions are creating potential growth opportunities for the Antithrombin market. According to the Centres for Disease Control and Prevention (CDC), venous thromboembolism affects about 900,000 people in the United States each year. Furthermore, hereditary thrombophilia puts 5 to 8% of the population in the United States at risk of thrombosis due to one of many genetic risk factors. Clopidogrel, a currently approved antiplatelet agent, meets some of these requirements and has contributed significantly to the antithrombotic market's recent development. Furthermore, the use of antithrombin and heparin may be more effective in the treatment of patients with antithrombin disorders. Antithrombin benefits and applications contribute to the market's development. The rising number of surgeries conducted worldwide and the risk of excessive bleeding during these procedures is expected to boost the market growth. Along with this, Therapeutic drug advances are also expected to drive market growth. Fitusiran (ALN-AT3), a subcutaneously administered investigational RNAi therapeutic targeting antithrombin, was developed by Alnylam Pharmaceuticals, Inc. (AT). This therapeutic, which can be used to treat hemophilia and rare bleeding disorders (RBDs), is currently in a late-stage clinical trial (Phase 2-phase 3). However, the high cost for antithrombin procedure and lack of adequate technological infrastructure in underdeveloped economies are expected to restrain the market growth. In addition to this, increased use of biologics and availability of alternative options may also impact negatively on the market growth. The report has profiled seventeen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Antithrombin Market Segment Analysis:
The global Antithrombin market is segmented on the basis of Application, Source and Dosage form. Based on the Application, the Therapeutics segment is anticipated to hold the largest market share over the forecast period. It accounted for a market share of 95% in the year 2022. It has widespread application in the therapeutics area. Antithrombin can be used to treat conditions such as heart surgery and genetic disorders such as Antithrombin Deficiency. According to data released by the American Society of Haematology, 900,000 people in the United States produce blood clots per year, resulting in nearly 100,000 deaths. According to the National Organization for Rare Disorders, Type I antithrombin deficiency affects one in every 3000 to 5000 individuals in the United States. Antithrombin is being used both therapeutically and diagnostically as the incidence of blood clotting disorders rises. Based on Dosage Form, the Lyophilized segment held the largest market share in 2022. The lyophilized dosage type is commonly available and has a long expiration date. It also contributes to the growth of this segment by maximizing the integrity and ease of processing a liquid.Antithrombin Market Regional Insights:
North America is anticipated to account for dominant market share during forecast period. The U.S. accounted for US$143.3 Million in the year 2022. This is due to a rise in antithrombin awareness, acceptance, and adoption in this region's countries. The popularity of antithrombin is growing in this area due to an increase in the number of people with coagulation disorders. Asia Pacific is expected to witness lucrative growth during forecast years. Asia Pacific Antithrombin Market is expected to expand at the fastest pace. The Antithrombin Market was worth US$ 179.7 million in the Asia Pacific alone in 2018. One of the main reasons for this increase is that developing countries like India and China are introducing new treatment procedures and techniques to combat different diseases. The report also helps in understanding Global Antithrombin Market dynamics, structure by analyzing the market segments and project the Global Antithrombin Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Antithrombin Market make the report investor’s guide.Antithrombin Market, Key developments:
Three major corporations dominated the global Antithrombin Market: SCL Behring, Grifols, and Shire. These three firms accounted for the largest market share among others in 2022. They have the most widely used anticoagulants dependent on human antithrombin. Apart from this, they have a wide distribution network that allows them to capture the largest market share.Antithrombin Market Scope: Inquire before buying
Global Antithrombin Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 604.18 Mn. Forecast Period 2023 to 2029 CAGR: 4.5% Market Size in 2029: US $ 822.20 Mn. Segments Covered: by Source Human Recombinant Goat milk Others by Dosage Type Lyophilized Liquid by Application Therapeutics Diagnostics Research Other Antithrombin Market, By Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Antithrombin Market Key Players are:
1. rEVO Biologics, Inc. 2. Grifols 3. CSL Limited 4. Kedrion S.p.A 5. Octapharma AG 6. Dem ilac Inc. 7. Lee Bisolutions 8. Diapharma 9. Scripps Laboratories, Inc. 10.LFB USA 11.Shire Plc. 12.Takeda Pharmaceutical Company Limited 13.Koliber Biosciences 14.Siemens Healthcare Private Limited 15.Aniara Diagnostica 16.Sysmex Corporation 17.Trinity Biotech PLC Frequently Asked questions 1. What is the market size of the Global Antithrombin Market in 2022? Ans. The market size Global Antithrombin Market in 2022 was US$ 604.18 Million. 2. What are the different segments of the Global Antithrombin Market ? Ans. The Global Antithrombin Market is divided into Source, Application and Dosage Type . 3. What is the study period of this market? Ans. The Global Antithrombin Market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global Antithrombin Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Antithrombin Market ? Ans. The Forecast Period of the market is 2023-2029 in the market.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Antithrombin Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Antithrombin Market 3.4. Geographical Snapshot of the Antithrombin Market, By Manufacturer share 4. Global Antithrombin Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Antithrombin Market 5. Supply Side and Demand Side Indicators 6. Global Antithrombin Market Analysis and Forecast, 2022-2029 6.1. Global Antithrombin Market Size & Y-o-Y Growth Analysis. 7. Global Antithrombin Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.1.1. Therapeutics 7.1.2. Diagnostics 7.1.3. Research 7.1.4. Other 7.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 7.2.1. Human 7.2.2. Recombinant Goat milk 7.2.3. Others 7.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 7.3.1. Lyophilized 7.3.2. Liquid 8. Global Antithrombin Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Antithrombin Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.1.1. Therapeutics 9.1.2. Diagnostics 9.1.3. Research 9.1.4. Other 9.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 9.2.1. Human 9.2.2. Recombinant Goat milk 9.2.3. Others 9.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 9.3.1. Lyophilized 9.3.2. Liquid 10. North America Antithrombin Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Antithrombin Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 12. Canada Antithrombin Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 13. Mexico Antithrombin Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 14. Europe Antithrombin Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 15. Europe Antithrombin Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Antithrombin Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 17. France Antithrombin Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 18. Germany Antithrombin Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 19. Italy Antithrombin Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 20. Spain Antithrombin Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 21. Sweden Antithrombin Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 22. CIS Countries Antithrombin Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 23. Rest of Europe Antithrombin Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 24. Asia Pacific Antithrombin Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 25. Asia Pacific Antithrombin Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Antithrombin Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 27. India Antithrombin Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 28. Japan Antithrombin Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 29. South Korea Antithrombin Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 30. Australia Antithrombin Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 31. ASEAN Antithrombin Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 32. Rest of Asia Pacific Antithrombin Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 33. Middle East Africa Antithrombin Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 34. Middle East Africa Antithrombin Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Antithrombin Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 36. GCC Countries Antithrombin Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 37. Egypt Antithrombin Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 38. Nigeria Antithrombin Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 39. Rest of ME&A Antithrombin Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 40. South America Antithrombin Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 41. South America Antithrombin Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Antithrombin Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 43. Argentina Antithrombin Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 44. Rest of South America Antithrombin Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Source, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By Dosage Form, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Antithrombin Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. rEVO Biologics, Inc. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Grifols 45.3.3. CSL Limited 45.3.4. Kedrion S.p.A 45.3.5. Octapharma AG 45.3.6. Dem ilac Inc. 45.3.7. Lee Bisolutions 45.3.8. Diapharma 45.3.9. Scripps Laboratories, Inc. 45.3.10. LFB USA 45.3.11. Shire Plc. 45.3.12. Takeda Pharmaceutical Company Limited 45.3.13. Koliber Biosciences 45.3.14. Siemens Healthcare Private Limited 45.3.15. Aniara Diagnostica 45.3.16. Sysmex Corporation 45.3.17. Trinity Biotech PLC 46. Primary Key Insights